|
Development of polyphosphate parameters for use with the AMBER force field
|
journal
|
July 2003 |
|
THE weighted histogram analysis method for free-energy calculations on biomolecules. I. The method
|
journal
|
October 1992 |
|
Mechanisms of guanosine triphosphate hydrolysis by Ras and Ras-GAP proteins as rationalized by ab initio QM/MM simulations
|
journal
|
November 2006 |
|
Optimizing Expression and Solubility of Proteins in E. coli Using Modified Media and Induction Parameters
|
book
|
May 2017 |
|
Gateway Cloning for Protein Expression
|
book
|
January 2009 |
|
Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes
|
journal
|
March 1977 |
|
Three-dimensional structures of H-ras p21 mutants: Molecular basis for their inability to function as signal switch molecules
|
journal
|
August 1990 |
|
Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase
|
journal
|
November 1991 |
|
Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor
|
journal
|
May 1993 |
|
Electrostatic interaction of a solute with a continuum. A direct utilizaion of AB initio molecular potentials for the prevision of solvent effects
|
journal
|
February 1981 |
|
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
|
journal
|
February 2022 |
|
Quantum chemical modeling of the GTP hydrolysis by the RAS–GAP protein complex
|
journal
|
July 2004 |
|
GEFs and GAPs: Critical Elements in the Control of Small G Proteins
|
journal
|
June 2007 |
|
Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by 31P NMR
|
journal
|
February 2024 |
|
Protein production by auto-induction in high-density shaking cultures
|
journal
|
May 2005 |
|
Homogeneous Dual-Parametric-Coupled Assay for Simultaneous Nucleotide Exchange and KRAS/RAF-RBD Interaction Monitoring
|
journal
|
February 2020 |
|
Ras Conformational Ensembles, Allostery, and Signaling
|
journal
|
January 2016 |
|
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor
|
journal
|
December 2021 |
|
Hydrolysis of Guanosine Triphosphate (GTP) by the Ras·GAP Protein Complex: Reaction Mechanism and Kinetic Scheme
|
journal
|
September 2015 |
|
Specific Substates of Ras To Interact with GAPs and Effectors: Revealed by Theoretical Simulations and FTIR Experiments
|
journal
|
February 2018 |
|
Structure-Based Design and Evaluation of Reversible KRAS G13D Inhibitors
|
journal
|
December 2023 |
|
Recent Advances in Understanding Biological GTP Hydrolysis through Molecular Simulation
|
journal
|
February 2020 |
|
How Does GAP Catalyze the GTPase Reaction of Ras?: A Computer Simulation Study
|
journal
|
July 2000 |
|
Ras Catalyzes GTP Hydrolysis by Shifting Negative Charges from γ - to β -Phosphate As Revealed by Time-Resolved FTIR Difference Spectroscopy †
|
journal
|
March 2001 |
|
Role of Glutamine-61 in the Hydrolysis of GTP by p21H-ras: An Experimental and Theoretical Study
|
journal
|
March 1994 |
|
Conformational States of Ras Complexed with the GTP Analogue GppNHp or GppCH 2 p: Implications for the Interaction with Effector Proteins †
|
journal
|
February 2005 |
|
Transition State Structures and the Roles of Catalytic Residues in GAP-Facilitated GTPase of Ras As Elucidated by 18 O Kinetic Isotope Effects
|
journal
|
June 2009 |
|
DFTB3: Extension of the Self-Consistent-Charge Density-Functional Tight-Binding Method (SCC-DFTB)
|
journal
|
March 2011 |
|
Ab Initio Calculation of Vibrational Absorption and Circular Dichroism Spectra Using Density Functional Force Fields
|
journal
|
November 1994 |
|
Enzymatic GTP Hydrolysis: Insights from an ab Initio Molecular Dynamics Study
|
journal
|
March 2002 |
|
Hydrogen Bonding between Amino Acid Backbone and Side Chain Analogues: A High-Level ab Initio Study
|
journal
|
December 1997 |
|
Simultaneous Covalent Modification of K-Ras(G12D) and K-Ras(G12C) with Tunable Oxirane Electrophiles
|
journal
|
August 2023 |
|
GTP Hydrolysis Without an Active Site Base: A Unifying Mechanism for Ras and Related GTPases
|
journal
|
June 2019 |
|
Determination of Alkali and Halide Monovalent Ion Parameters for Use in Explicitly Solvated Biomolecular Simulations
|
journal
|
July 2008 |
|
Mechanism of activation of a human oncogene
|
journal
|
November 1982 |
|
A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene
|
journal
|
November 1982 |
|
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change
|
journal
|
December 1982 |
|
Biological properties of human c-Ha-ras1 genes mutated at codon 12
|
journal
|
November 1984 |
|
RanGAP mediates GTP hydrolysis without an arginine finger
|
journal
|
February 2002 |
|
The KRAS crowd targets its next cancer mutations
|
journal
|
January 2023 |
|
The Rap–RapGAP complex: GTP hydrolysis without catalytic glutamine and arginine residues
|
journal
|
February 2008 |
|
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|
journal
|
November 2013 |
|
Substrate-assisted catalysis as a mechanism for GTP hydrolysis of p21ras and other GTP-binding proteins
|
journal
|
January 1995 |
|
KRAS mutation: from undruggable to druggable in cancer
|
journal
|
November 2021 |
|
RAS-targeted therapies: is the undruggable drugged?
|
journal
|
June 2020 |
|
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
|
journal
|
October 2019 |
|
Pan-KRAS inhibitor disables oncogenic signalling and tumour growth
|
journal
|
May 2023 |
|
Pharmacological restoration of GTP hydrolysis by mutant RAS
|
journal
|
October 2024 |
|
Comparison of simple potential functions for simulating liquid water
|
journal
|
July 1983 |
|
A complete basis set model chemistry. II. Open‐shell systems and the total energies of the first‐row atoms
|
journal
|
May 1991 |
|
Particle mesh Ewald: An N ⋅log( N ) method for Ewald sums in large systems
|
journal
|
June 1993 |
|
A smooth particle mesh Ewald method
|
journal
|
November 1995 |
|
Kinetic isotope effects in Ras-catalyzed GTP hydrolysis: Evidence for a loose transition state
|
journal
|
June 2004 |
|
A phosphoryl transfer intermediate in the GTPase reaction of Ras in complex with its GTPase-activating protein
|
journal
|
September 2006 |
|
Dynamic properties of the Ras switch I region and its importance for binding to effectors
|
journal
|
April 2001 |
|
Allosteric modulation of Ras positions Q61 for a direct role in catalysis
|
journal
|
March 2010 |
|
Quantitative exploration of the molecular origin of the activation of GTPase
|
journal
|
November 2013 |
|
Purification of ras GTPase activating protein from bovine brain.
|
journal
|
July 1988 |
|
Ras-catalyzed hydrolysis of GTP: a new perspective from model studies.
|
journal
|
August 1996 |
|
Conformational States of Human Rat Sarcoma (Ras) Protein Complexed with Its Natural Ligand GTP and Their Role for Effector Interaction and GTP Hydrolysis
|
journal
|
October 2010 |
|
The Mechanism for Activation of GTP Hydrolysis on the Ribosome
|
journal
|
November 2010 |
|
The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants
|
journal
|
July 1997 |
|
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS
|
journal
|
August 2023 |
|
The Frequency of Ras Mutations in Cancer
|
journal
|
March 2020 |
|
Abstract 1142: Discovery of FMC-376 a novel orally bioavailable inhibitor of activated KRASG12C
|
journal
|
April 2023 |
|
Abstract 526: RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRASG12D cancers
|
journal
|
April 2023 |
|
Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations
|
journal
|
June 2015 |
|
Atypical KRAS G12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer
|
journal
|
October 2019 |
|
Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants
|
journal
|
January 2022 |
|
Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12C
|
journal
|
December 2024 |
|
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
|
journal
|
August 2022 |
|
The path to the clinic: a comprehensive review on direct KRASG12C inhibitors
|
journal
|
January 2022 |
|
More to the RAS Story: KRASG12C Inhibition, Resistance Mechanisms, and Moving Beyond KRASG12C
|
journal
|
July 2022 |
|
Small molecular inhibitors for KRAS-mutant cancers
|
journal
|
August 2023 |
|
Ras history: The saga continues
|
journal
|
July 2010 |